Found 544 hits.
| 60 | Młynek, A., Zalewska-Janowska, A., Martus, P., Staubach, P., Zuberbier, T., and Maurer, M.+: How to assess disease activity in patients with chronic urticaria? Allergy 2008: 63; 777-780. IF: 6.20 |
| 132 | Weller, K., Viehmann, K., Bräutigam, M., Krause, K., Siebenhaar, F., Zuberbier, T., and Maurer, M.+: Cost-intensive, time-consuming, problematical? – How physicians in private practice experience the care of urticaria patients. J. Dtsch. Dermatol. Ges. 2012: 10; 341-347. IF: 1.40 |
| 400. | Maurer, M.+, Costa, C., Giménez-Arnau, A., Guillet, G., Labrador-Horrillo, M., Lapeere, H., Meshkova, R., Savic, S., and Chapman-Rothe, N.: Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study. Clin. Exp. Allergy 2020: 50; 1166-1175 IF: 5.02 |
o.400
| 105. | Maurer, M., Vena, G. A., Cassano, N., and Zuberbier, T.: Current and future therapies for treating chronic spontaneous urticaria. Expert Opin. Pharmacother. 2016: 17; 1131-1139. IF: 3.89 |
r.105
This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Devel- opment and Evaluation (GRADE) working
| 6. | Magerl, M. and Maurer, M.: Hereditäres Angioödem, In: Schöfer, H. and Baur-Beger, S., editors: Derma-Net-Online: Aktuelle Dermatologie für Dermatologen und dermatologisch Interessierte (www.derma-net-online.de), 2007 |
| 116 | Weller, K., Ziege, C., Staubach, P., Brockow, K., Siebenhaar, F., Krause, K., Altrichter, S., Church, M. K., and Maurer, M.+: H1-Antihistamine up-dosing in chronic spontaneous urticaria: Patients’ perspective of effectiveness and side effects – a retrospective survey study. PLoS ONE 2011: 6; e23931. IF: 4.09 |
|
471. |
Zuberbier, T.+, Abdul Latiff, A. H., Abuzakouk, M., Aquilina, S., Asero, R., Baker, D., Ballmer-Weber, B., Bangert, C., Ben-Shoshan, M., Bernstein, J. A., Bindslev-Jensen, C., Brockow, K., Brzoza, Z., Chong Neto, H. J., Church, M. K., Criado, P. R., Danilycheva, I. V., Dressler, C., Ensina, L. F., Fonacier, L., Gaskins, M., Gáspár, K., Gelincik, A., Giménez-Arnau, A., Godse, K., Gonçalo, M., Grattan, C., Grosber, M., Hamelmann, E., Hébert, J,. Hide, M., Kaplan, A., Kapp, A., Kessel, A., Kocatürk, E., Kulthanan, K., Larenas-Linnemann, D., Lauerma, A., Leslie, T. A., Magerl, M., Makris, M., Meshkova, R. Y., Metz, M., Micallef, D., Mortz, C. G., Nast, A., Oude-Elberink, H., Pawankar, R., Pigatto, P. D., Ratti Sisa, H., Rojo Gutiérrez, M. I., Saini, S. S., Schmid-Grendelmeier, P., Sekerel, B. E., Siebenhaar, F., Siiskonen, H., Soria, A., Staubach-Renz, P., Stingeni, L., Sussman, G., Szegedi, A., Thomsen, S. F., Vadasz, Z., Vestergaard, C., Wedi, B., Zhao, Z., and Maurer M.: The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy 2022: 77; 734-766. IF: 12.40 |
o.471
| 167. | Maltseva, N., Borzova, E., Fomina, D., Bizjak, M., Terhorst-Molawi, D., Košnik, M., Kulthanan, K., Meshkova, R., Thomsen, S. F., and Maurer, M.+: Cold urticaria – what we know and what we do not know. Allergy 2021: in press. IF: 14.71 |
r.167
| 39. | Kröpfl, L., Maurer, M., and Zuberbier, T.: Treatment strategies in urticaria. Expert Opin. Pharmacother. 2010: 11; 1445-1450. IF: 2.40 |